Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001387554 | SCV001588219 | pathogenic | not provided | 2023-07-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1074306). This premature translational stop signal has been observed in individual(s) with CYP17A1-related conditions (PMID: 18422032, 21966534). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg358*) in the CYP17A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP17A1 are known to be pathogenic (PMID: 10720067, 14747197, 17192295, 20197673, 24140098). |
Baylor Genetics | RCV001826177 | SCV005059302 | pathogenic | Deficiency of steroid 17-alpha-monooxygenase | 2024-02-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826177 | SCV002086169 | pathogenic | Deficiency of steroid 17-alpha-monooxygenase | 2021-03-23 | no assertion criteria provided | clinical testing |